ReviewBritish journal of cancer2020

Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer.

Francis W Hunter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.